✦ LIBER ✦

Beyond first-line NSCLC therapy: chemotherapy or erlotinib?

✍ Scribed by Luis Paz-Ares

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-line erlotinib shows promising act

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 121 KB

Intercalated chemotherapy and erlotinib:

✍ Zheng, Yulong; Xu, Nong; Zhou, Jianying 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 38 KB

9158 A phase III study of erlotinib as m

✍ Cappuzzo, F.; Coudert, B.; Wierzbicki, R.; Park, K.; Custers, F.; Curbera, G.A.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Intercalated chemotherapy and erlotinib:

✍ Mok, Tony S K; Wu, Yi-Long 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 48 KB

18 NSCLC second line therapy with erloti

✍ Urquhart, G.; Semple, E.; Steven, E.; Kerr, K.; Nicolson, M. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 34 KB

First-line chemotherapy for NSCLC: an ov

✍ Belani, Chandra P; Langer, Corey 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 124 KB